Alphatec Holdings, Inc.
Alphatec Holdings, Inc. designs and develops medical technologies for spinal disorders treatment. It manufactures implants and instruments through third-party suppliers. The company offers various products, including imaging systems, alignment tools, and robotics-based intra-operative systems. Products also include spinal implants, fixation systems, and biologics such as bone grafts and tissue barriers. Sales are made through a network of independent agents and direct sales representatives. Founded in 1990, the company is headquartered in Carlsbad, California.
Overview
Strengths
- Consistent growth: revenue has compounded at 37.4% a year over 6 years, rising every year.
- Skin in the game: insiders own 20% of the shares, aligning management with shareholders.
- Paying down debt: long-term debt fell by 10.7 percentage points of total assets last year.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 7.8%) has been below its cost of capital of 8.1% in each of the last 7 years.
- Operating profit does not cover interest expense.
- Our discounted cash flow model finds no value to support the current price: operating profit does not cover interest expense.
- Shareholder dilution: the share count has grown by 11.7% a year over the last three years.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 7 of the last 7 years.
Key Financial Data